paclitaxel

(redirected from Onxol)
Also found in: Medical.
Related to Onxol: Taxol

pac·li·tax·el

 (păk′lĭ-tăk′səl)
n.
An anticancer drug that was first derived from the bark of the Pacific yew tree and is used in the treatment of ovarian and breast cancer that has not responded to prior therapy.

[Pac(ific yew) + New Latin (brevifō)li(a), specific epithet of the Pacific yew (Latin brevis, short + Latin fōlium, leaf; see folium) + alteration of Taxol.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

paclitaxel

(ˌpæklɪˈtæksəl)
n
(Medicine) a drug derived from the yew tree and used to treat cancer
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
Translations

paclitaxel

n paclitaxel m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
In addition to the previously mentioned cefaclor, Ivax was given the nod to market the hypertension drugs enalapril and doxazosin; fluvoxamine, a treatment for Obsessive Compulsive Disorder; and Onxol, an injectable version of the anticancer drug paclitaxel.
One of the company's recent winners and the engine of its projected growth is paclitaxel, sold as Onxol in the United States and Paxene elsewhere.
A major portion of that gain should include an estimated $125 million in sales of paclitaxel (called Onxol), which is the generic equivalent of Bristol-Myers' Taxol anticancer drug.